Related Experiment Video
Updated: Jun 10, 2025
10:56
Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality
Published on: May 5, 2022
13.5K
Organoids-On-a-Chip for Personalized Precision Medicine
Yunqi Man1, Yanfei Liu2, Qiwen Chen2
1Department of Pharmaceutics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, P. R. China.
Advanced Healthcare Materials
|October 14, 2024
Summary
Organoids-on-a-Chip (OoCs) advance personalized precision medicine by using patient organoids for tailored treatments, disease modeling, and drug screening. This technology revolutionizes healthcare and improves patient outcomes through individualized strategies.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Pharmacology
Background:
- Personalized precision medicine is a key focus in modern healthcare.
- Organoids-on-a-Chip (OoCs) integrate organoid culture with microfluidic technology.
- OoCs offer a platform for patient-specific therapeutic strategies.
Purpose of the Study:
- To review the applications of OoCs in personalized precision medicine.
- To highlight OoCs as a cutting-edge technology for healthcare innovation.
- To discuss the potential of OoCs in optimizing patient treatments and disease modeling.
Main Methods:
- Utilizing patient-derived organoids within microfluidic chip systems.
- Exploring diverse applications including treatment optimization and drug screening.
- Reviewing advancements in genomic medicine and multi-omics integration.
Main Results:
- OoCs facilitate precise disease modeling and investigation of mechanisms.
- Patient-specific organoids enable individualized therapeutic strategies and drug screening.
- The fusion of technologies enhances treatment optimization and patient outcomes.
Conclusions:
- OoCs represent a significant advancement in personalized precision medicine.
- This technology has the potential to revolutionize healthcare delivery and patient care.
- Future prospects include integration with genomic medicine and ethical frameworks for enhanced patient empowerment.
